Marigold Inc follows IFRS and is adjusting and correcting its books at the end of 2023 . In reviewing its records, the following information has been compiled: 1. In 2023, the depreciation method on plant assets should be changed from the sum-of-the-years-digits to the straight-line method due to a change in pattern of usage. The assets were purchased at the beginning of 2022 for $82,800 with an estimated useful ilfe of four years and no residual value. Marigold has already recorded 2023 depreciation expense of $24,840 related to the assets, using the sum-of-the-years'-digits method. 2. Ending imventory for 2022 was overstated by $18,400; ending inventory for 2023 is correctly stated. 3. The adjusted trial balance at December 31,2021 , includes the following amounts: Cash $34,960; Inventory $103,040; Accounts Payable \$44,160; Retained Earnings $66,240. 4. Dividends of $27,600 and $23,000 were declared and paid on December 31,2023 , and December 31,2022, respectively 5. Share capital of $27,600 consists of 18,400 common shares outstanding since the company's inception. Marigold's statement of financial position and income statement are as follows at December 31,2022 and 2023 , before any corrections related to the information above. The December 31,2023 statements are in draft form only and the 2023 accounts have not yet been closed. MARIGOLDINC. Statement of Financial Position As at December 31, 2023 \begin{tabular}{lrc} Assets & 2023 & 2022 \\ Cash & $55,200 & $31,280 \\ Inventory & 98,440 & 117,760 \\ Plant assets, net & 24,840 & 49,680 \\ \hline Total assets & $178,480 & $198,720 \\ \hline \hline \end{tabular} Liabilities and Shareholders' Equity Accounts payable Share capital $15,640 $56,120 Retained earnings Total liabilities and shareholders' equity 27,600 27,600 135,240$178,480 115,000 $198,720 Prepare the comparative income statement for 2023. Ignore income taxeffects. (Round eamings per share to 2 decimal places, eg. 52.75.)